US Stock MarketDetailed Quotes

AIM AIM ImmunoTech

Watchlist
  • 0.3564
  • +0.0041+1.16%
Close Jul 25 16:00 ET
  • 0.3580
  • +0.0016+0.45%
Post 17:47 ET
20.36MMarket Cap-556P/E (TTM)

AIM ImmunoTech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-18.37%40K
43.26%202K
16.07%65K
119.05%46K
40.00%42K
48.48%49K
4.44%141K
12.00%56K
-36.36%21K
30.43%30K
Operating revenue
-18.37%40K
43.26%202K
16.07%65K
119.05%46K
40.00%42K
48.48%49K
4.44%141K
12.00%56K
-36.36%21K
30.43%30K
Cost of revenue
8K
42K
12K
30K
0
0
0
0
0
-75.27%69K
Gross profit
-34.69%32K
13.48%160K
-5.36%53K
-23.81%16K
207.69%42K
211.36%49K
119.72%141K
144.44%56K
116.94%21K
84.77%-39K
Operating expense
32.73%5.77M
59.87%32.08M
150.48%14.06M
24.93%8.17M
18.19%5.5M
39.77%4.34M
22.76%20.06M
1.30%5.61M
71.93%6.54M
34.49%4.66M
Selling and administrative expenses
66.45%3.82M
61.67%21.14M
209.76%10.86M
5.20%5.44M
16.92%2.55M
10.62%2.29M
50.76%13.07M
33.93%3.51M
187.38%5.17M
1.68%2.18M
-General and administrative expense
66.45%3.82M
61.67%21.14M
209.76%10.86M
5.20%5.44M
16.92%2.55M
10.62%2.29M
50.76%13.07M
33.93%3.51M
187.38%5.17M
1.68%2.18M
Research and development costs
-4.92%1.95M
56.49%10.94M
51.87%3.2M
99.27%2.73M
19.31%2.95M
98.07%2.05M
-8.89%6.99M
-27.92%2.11M
-31.61%1.37M
87.93%2.48M
Operating profit
-33.50%-5.73M
-60.20%-31.92M
-152.05%-14M
-25.09%-8.16M
-16.32%-5.46M
-36.26%-4.3M
-16.79%-19.92M
1.94%-5.56M
-65.97%-6.52M
-26.28%-4.7M
Net non-operating interest income expense
-95.48%9K
69.95%1.07M
-22.52%258K
70.93%294K
302.53%318K
342.22%199K
1,038.81%629K
433.00%333K
960.00%172K
146.88%79K
Non-operating interest income
-59.30%81K
69.95%1.07M
-22.52%258K
70.93%294K
302.53%318K
342.22%199K
--629K
433.00%333K
--172K
54.90%79K
Non-operating interest expense
--72K
----
----
----
--0
--0
----
----
----
--0
Other net income (expense)
-121.15%-92K
1,348.34%1.89M
40.29%1.17M
230.56%47K
199.57%234K
161.01%435K
92.45%-151K
1,142.50%834K
-129.27%-36K
89.27%-235K
Gain on sale of security
-145.32%-92K
112.17%200K
345.56%401K
14.84%-310K
79.87%-94K
122.48%203K
-2,835.71%-1.64M
215.38%90K
-813.73%-364K
-6,771.43%-467K
Special income (charges)
--0
500.00%18K
-33.33%2K
--39K
--0
---23K
100.07%3K
100.17%3K
--0
--0
-Gain on sale of property,plant,equipment
--0
500.00%18K
-33.33%2K
--39K
--0
---23K
-98.61%3K
--3K
--0
--0
Other non- operating income (expenses)
----
11.88%1.67M
3.51%767K
-3.05%318K
41.38%328K
34.21%255K
-35.75%1.49M
-58.30%741K
355.56%328K
-19.44%232K
Income before tax
-58.89%-5.82M
-48.94%-28.96M
-186.53%-12.58M
-22.41%-7.82M
-1.20%-4.91M
4.16%-3.66M
-1.66%-19.45M
24.92%-4.39M
-66.88%-6.39M
17.44%-4.85M
Income tax
Net income
-58.89%-5.82M
-48.94%-28.96M
-186.53%-12.58M
-22.41%-7.82M
-1.20%-4.91M
4.16%-3.66M
-1.66%-19.45M
24.92%-4.39M
-66.88%-6.39M
17.44%-4.85M
Net income continuous Operations
-58.89%-5.82M
-48.94%-28.96M
-186.53%-12.58M
-22.41%-7.82M
-1.20%-4.91M
4.16%-3.66M
-1.66%-19.45M
24.92%-4.39M
-66.88%-6.39M
17.44%-4.85M
Minority interest income
Net income attributable to the parent company
-58.89%-5.82M
-48.94%-28.96M
-186.53%-12.58M
-22.41%-7.82M
-1.20%-4.91M
4.16%-3.66M
-1.66%-19.45M
24.92%-4.39M
-66.88%-6.39M
17.44%-4.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-58.89%-5.82M
-48.94%-28.96M
-186.53%-12.58M
-22.41%-7.82M
-1.20%-4.91M
4.16%-3.66M
-1.66%-19.45M
24.92%-4.39M
-66.88%-6.39M
17.44%-4.85M
Basic earnings per share
-50.00%-0.12
-50.00%-0.6
-188.89%-0.26
-23.08%-0.16
0.00%-0.1
0.00%-0.08
0.00%-0.4
25.00%-0.09
-62.50%-0.13
16.67%-0.1
Diluted earnings per share
-50.00%-0.12
-50.00%-0.6
-188.89%-0.26
-23.08%-0.16
0.00%-0.1
0.00%-0.08
0.00%-0.4
25.00%-0.09
-62.50%-0.13
16.67%-0.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -18.37%40K43.26%202K16.07%65K119.05%46K40.00%42K48.48%49K4.44%141K12.00%56K-36.36%21K30.43%30K
Operating revenue -18.37%40K43.26%202K16.07%65K119.05%46K40.00%42K48.48%49K4.44%141K12.00%56K-36.36%21K30.43%30K
Cost of revenue 8K42K12K30K00000-75.27%69K
Gross profit -34.69%32K13.48%160K-5.36%53K-23.81%16K207.69%42K211.36%49K119.72%141K144.44%56K116.94%21K84.77%-39K
Operating expense 32.73%5.77M59.87%32.08M150.48%14.06M24.93%8.17M18.19%5.5M39.77%4.34M22.76%20.06M1.30%5.61M71.93%6.54M34.49%4.66M
Selling and administrative expenses 66.45%3.82M61.67%21.14M209.76%10.86M5.20%5.44M16.92%2.55M10.62%2.29M50.76%13.07M33.93%3.51M187.38%5.17M1.68%2.18M
-General and administrative expense 66.45%3.82M61.67%21.14M209.76%10.86M5.20%5.44M16.92%2.55M10.62%2.29M50.76%13.07M33.93%3.51M187.38%5.17M1.68%2.18M
Research and development costs -4.92%1.95M56.49%10.94M51.87%3.2M99.27%2.73M19.31%2.95M98.07%2.05M-8.89%6.99M-27.92%2.11M-31.61%1.37M87.93%2.48M
Operating profit -33.50%-5.73M-60.20%-31.92M-152.05%-14M-25.09%-8.16M-16.32%-5.46M-36.26%-4.3M-16.79%-19.92M1.94%-5.56M-65.97%-6.52M-26.28%-4.7M
Net non-operating interest income expense -95.48%9K69.95%1.07M-22.52%258K70.93%294K302.53%318K342.22%199K1,038.81%629K433.00%333K960.00%172K146.88%79K
Non-operating interest income -59.30%81K69.95%1.07M-22.52%258K70.93%294K302.53%318K342.22%199K--629K433.00%333K--172K54.90%79K
Non-operating interest expense --72K--------------0--0--------------0
Other net income (expense) -121.15%-92K1,348.34%1.89M40.29%1.17M230.56%47K199.57%234K161.01%435K92.45%-151K1,142.50%834K-129.27%-36K89.27%-235K
Gain on sale of security -145.32%-92K112.17%200K345.56%401K14.84%-310K79.87%-94K122.48%203K-2,835.71%-1.64M215.38%90K-813.73%-364K-6,771.43%-467K
Special income (charges) --0500.00%18K-33.33%2K--39K--0---23K100.07%3K100.17%3K--0--0
-Gain on sale of property,plant,equipment --0500.00%18K-33.33%2K--39K--0---23K-98.61%3K--3K--0--0
Other non- operating income (expenses) ----11.88%1.67M3.51%767K-3.05%318K41.38%328K34.21%255K-35.75%1.49M-58.30%741K355.56%328K-19.44%232K
Income before tax -58.89%-5.82M-48.94%-28.96M-186.53%-12.58M-22.41%-7.82M-1.20%-4.91M4.16%-3.66M-1.66%-19.45M24.92%-4.39M-66.88%-6.39M17.44%-4.85M
Income tax
Net income -58.89%-5.82M-48.94%-28.96M-186.53%-12.58M-22.41%-7.82M-1.20%-4.91M4.16%-3.66M-1.66%-19.45M24.92%-4.39M-66.88%-6.39M17.44%-4.85M
Net income continuous Operations -58.89%-5.82M-48.94%-28.96M-186.53%-12.58M-22.41%-7.82M-1.20%-4.91M4.16%-3.66M-1.66%-19.45M24.92%-4.39M-66.88%-6.39M17.44%-4.85M
Minority interest income
Net income attributable to the parent company -58.89%-5.82M-48.94%-28.96M-186.53%-12.58M-22.41%-7.82M-1.20%-4.91M4.16%-3.66M-1.66%-19.45M24.92%-4.39M-66.88%-6.39M17.44%-4.85M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -58.89%-5.82M-48.94%-28.96M-186.53%-12.58M-22.41%-7.82M-1.20%-4.91M4.16%-3.66M-1.66%-19.45M24.92%-4.39M-66.88%-6.39M17.44%-4.85M
Basic earnings per share -50.00%-0.12-50.00%-0.6-188.89%-0.26-23.08%-0.160.00%-0.10.00%-0.080.00%-0.425.00%-0.09-62.50%-0.1316.67%-0.1
Diluted earnings per share -50.00%-0.12-50.00%-0.6-188.89%-0.26-23.08%-0.160.00%-0.10.00%-0.080.00%-0.425.00%-0.09-62.50%-0.1316.67%-0.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Cannabis
Cannabis
Intraday+1.21%